Stone Crest Wealth Management, Inc. Argenx Se Transaction History
Stone Crest Wealth Management, Inc.
- $153 Billion
- Q4 2024
A detailed history of Stone Crest Wealth Management, Inc. transactions in Argenx Se stock. As of the latest transaction made, Stone Crest Wealth Management, Inc. holds 731 shares of ARGX stock, worth $471,114. This represents 0.29% of its overall portfolio holdings.
Number of Shares
731
Previous 733
0.27%
Holding current value
$471,114
Previous $397 Million
13.14%
% of portfolio
0.29%
Previous 0.29%
Shares
5 transactions
Others Institutions Holding ARGX
# of Institutions
432Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.56 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.98 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.49 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.15 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$798 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...